Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
UBS
McKinsey
Covington
Federal Trade Commission
Harvard Business School

Generated: July 18, 2019

DrugPatentWatch Database Preview

Patent: 7,892,563

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,892,563
Title:Methods for treatment of severe acute respiratory syndrome (SARS)
Abstract: Compositions and methods for treating Severe Acute Respiratory Syndrome (SARS) are disclosed herein. Inhibitors of SARS-associated inflammatory cytokines are provided herein for use in treating SARS, including SARS-associated coronavirus (SARS-CoV) infection. Inhibitors of TNF are disclosed herein, as is the use of said inhibitors for treating SARS, including SARS-CoV. Methods of identifying and screening for said inhibitors are also provided.
Inventor(s): Siber; George R. (Irvington, NY)
Assignee: Wyeth Holdings Corporation (Madison, NJ)
Application Number:10/441,059
Patent Claims:see list of patent claims

Details for Patent 7,892,563

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Try a Free Trial Wyeth Holdings Corporation (Madison, NJ) ➤ Try a Free Trial RX Orphan search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02 ➤ Try a Free Trial Wyeth Holdings Corporation (Madison, NJ) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,892,563

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2005018535 Dec 21, 2006
World Intellectual Property Organization (WIPO) 2005018535 Mar 03, 2005
United States of America 2004235047 Nov 25, 2004
United States of America 2006263847 Nov 23, 2006
United States of America 7722886 May 25, 2010
Russian Federation 2005139730 May 10, 2006
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Boehringer Ingelheim
Healthtrust
QuintilesIMS
Johnson and Johnson
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.